• 

  Another Alzheimer’s Trial Cancelled: Lilly, Roche Drugs Fail to Reduce Beta-Amyloid
• 

  Researchers Pinpoint Genetic Mutations That May Protect Against Alzheimer’s
• 

  Fighting Proteins with Proteins: CPPs May Counter Amyloid Buildup
• 

  FDA Approves Insomnia Drug, Suvorexant, for Alzheimer’s Patients
• 

  How Flavonols, Found in Fruit and Tea, Can Stave Off Alzheimer’s
• 

  Artificial Intelligence Analyzes Blood Samples, Accurately Predicts Alzheimer’s
• 

  Researchers Explore Lithium as Treatment for Alzheimer’s Disease
• 

  FDA Gives Biogen Green Light to Relaunch Aducanumab Study on Trial Participants
• 

  Researchers Pinpoint Protein, ‘Aggregatin,’ as New Biomarker for Alzheimer’s
• 

  A New Eye Test May Allow Early Detection of Alzheimer’s: Dr. Peter Snyder
• 

  ‘Pharmacological Chaperones’ May Help Treat Alzheimer’s By Clearing Harmful Proteins From Brain
• 

  Ovarian Cancer Protein May Worsen Alzheimer’s Neurodegeneration
• 

  Biogen Plans to Buy Early-Stage Alzheimer’s and Parkinson’s Treatment From Pfizer
• 

  Could an Eye Exam Detect Alzheimer’s? Researchers Launch Retinal Imaging Study
• 

  Evidence Staying Active Slows Onset of Frontotemporal Dementia

Previous343536Next